Rate My Professor Leon Warne

Leon Warne is a veterinary anaesthesia and pain management specialist serving as an adjunct professor at Murdoch University. He earned his Bachelor of Veterinary Medicine and Surgery (BVMS) from Murdoch University in 2009, along with Bachelor of Science (Biology), Bachelor of Biomedical Science (Honours Class 1), and Bachelor of Science degrees. Warne completed a Master of Veterinary Studies and a PhD in pain management and assessment at the University of Melbourne's Melbourne Veterinary School. He is a Diplomate of the American College of Veterinary Anesthesia and Analgesia (DACVAA), a Member of the Australian and New Zealand College of Veterinary Scientists anaesthesia chapter (MANZCVS), and an Australasian Veterinary Boards Council registered specialist in anaesthesia.

After graduation, Warne undertook an internship in anaesthesia, emergency, and critical care medicine. In 2010, he joined the University of Melbourne, completing specialty training in anaesthesia and pain management, his master's degree, PhD, and a 2015 externship in anaesthesia and trauma management at The Austin and Royal Melbourne Hospitals. He held the position of Lecturer in Veterinary Anaesthesia in the College of Veterinary Medicine, School of Veterinary and Life Sciences at Murdoch University. Warne is Director of Veterinary Anaesthesia and Pain Management Australia, senior research fellow at Curtin University, founder and medical director of The Vet Pharmacist, and serves on the Executive Committee of the Australian Small Animal Veterinarians. His research focuses on the efficacy of medicinal cannabis across multiple species, quality of life as a primary outcome measure for chronic disease, and assessment and management strategies for complex pain disorders. Notable publications include 'Standards of Care: Anaesthesia Guidelines for Dogs and Cats' (Australian Veterinary Journal, 2018), 'A Review of the Pharmacology and Clinical Application of Alfaxalone in Cats' (Veterinary Journal, 2015), 'Content Validation of a Critical Appraisal Tool for Reviewing Case Reports and Case Series' (2018), 'Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy of a GPR119 Agonist in Diet-Induced Obese Mice' (2024), 'Comprehensive Assessment of Cannabidiol and HU308 in Experimental Colitis' (2024), and 'Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in Experimental Colitis' (2025).